mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.8 |